VIVCAPITAL
US FAMILY OFFICES & LPs · India ↔ United States

Build India exposure without outsourcing judgment to the seller.

For US family offices, endowments and private investors evaluating India, VIV acts as an independent India-side diligence, monitoring and portfolio-value partner — from manager and company verification through follow-on decisions, strategic access and exit preparation.

V

Value

Find where capital can be protected, improved or realized.

I

Independence

The family is the client; VIV is not paid by a startup to sell the deal.

V

Visibility

Verify what is owned, what changed and what evidence supports the investment case.

THE COUNTRY PARTNER MODEL

One relationship. Two-way value.

VIV is not simply a source of Indian deals. The model connects a United States family's investment mandate and operating capabilities with independently verified Indian companies — and can help portfolio companies access relevant customers, suppliers, distribution, expertise or strategic buyers when both sides consent.

WHAT VIV CAN DO

Built around the actual mandate, not generic deal flow.

The exact work depends on the family's existing exposure, direct-investment appetite, sector knowledge, team depth and India objectives.

01

India company and founder diligence

Delivered against the family's written mandate and the evidence available for the specific opportunity.

02

Independent co-investment challenge

Delivered against the family's written mandate and the evidence available for the specific opportunity.

03

Portfolio-company India execution

Delivered against the family's written mandate and the evidence available for the specific opportunity.

04

Customer and strategic-partner introductions

Delivered against the family's written mandate and the evidence available for the specific opportunity.

05

Ongoing monitoring and exception reporting

Delivered against the family's written mandate and the evidence available for the specific opportunity.

06

Secondary and strategic-exit support

Delivered against the family's written mandate and the evidence available for the specific opportunity.

SECTOR BRIDGES

Where the corridor may be commercially useful.

These are positioning themes for discussion, not claims that every family in United States follows the same mandate.

Technology & enterpriseHealthcare & life sciencesDeep techConsumerSpecialty manufacturing

VIV first captures the family's actual mandate and capabilities before sourcing or introducing opportunities.

HOW AN ENGAGEMENT STARTS

Mandate → evidence → action.

No public deal marketplace. No mass introductions. The process begins privately with what the family wants to own, avoid, verify or solve.

Define the mandate

Ticket, sectors, stage, geography, return/risk expectations, direct vs fund exposure, strategic capabilities and exclusions.

Map and verify

Identify relevant opportunities or existing exposures, then verify management, financial, customer, market and ownership evidence.

Challenge the decision

Show what supports the case, what contradicts it, what remains unknown and what conditions should precede a cheque or follow-on.

Stay after the cheque

Monitor changes, activate useful cross-border capabilities, review follow-ons and prepare liquidity or strategic-exit pathways.

US PRIVATE CONVERSATION

Tell us the India problem you need solved — not the product you want pitched.

Discuss the mandate
COUNTRY INTELLIGENCE · FACTS + VIV INTERPRETATION

United States needs its own investment thesis.

Verified corridor facts are separated from VIV's proposed service thesis. Sector priorities remain hypotheses until the family's mandate is known.

2025 corridor

US–India goods and services trade was estimated at $239.6B in 2025.

Official source ↗
WHO / WHY / WHAT

Different buyer. Different reason to use VIV.

Likely family / LP archetypes

  • US entrepreneurial family office
  • US LP evaluating Indian VC/PE managers
  • Indian-origin US family
  • Strategic investor

Priority corridor themes

  • Enterprise software & AI
  • Healthcare / life sciences
  • Deep tech
  • Advanced manufacturing
  • Consumer / fintech

What they may need from India

  • Local founder/customer/supplier references
  • Direct and co-investment challenge
  • Indian manager diligence
  • Local monitoring
  • Secondary / buyer mapping

What can flow back to Indian companies

  • US enterprise customers
  • Growth capital networks
  • Product / GTM expertise
  • Strategic acquirers
TWO-SIDED CORRIDOR

Capital is one edge. Capability can be the second.

UNITED STATES FAMILY / LP

Mandate + capital + capability

Customers, distribution, technology, manufacturing, expertise, strategic relationships or patient capital.

↔
VERIFIED INDIA COMPANY

Investment + operating opportunity

VIV tests investment quality and strategic synergy separately. One does not excuse weakness in the other.

MANDATE SCENARIO

Make the corridor concrete.

A US family office wants $5–15M India technology exposure. VIV defines the mandate, verifies shortlisted companies locally, challenges valuation and terms, and remains the India-side monitoring layer.

Service scenario; not a client case, investment offer or performance claim.

PRIVATE · CONTEXTUAL · NO MASS DISTRIBUTION

Discuss a United States–India mandate

Tell us enough to understand the problem. We use the information to route the conversation to the relevant VIV service; it is not a public deal submission.

Start with the problem

Please share only what is needed for an initial conversation. By submitting, you agree that VIV may use these details to respond. Submission does not create an advisory relationship.

INDIA ↔ US · OPERATING MODEL

How VIV works the United States corridor.

Family / LP side

  • Technology And Enterprise Software
  • Healthcare / Life Sciences
  • Consumer And Brand Expansion
  • Strategic And Financial Capital

Portfolio-company side

  • Us Customer Access
  • Specialist Operators
  • Growth / Strategic Capital
  • Strategic-Buyer Pathways
STEP 01

Define the family / LP mandate

STEP 02

Map a corridor-specific opportunity and capability universe

STEP 03

Verify locally and independently

STEP 04

Activate capital, customers, partners or operators only where fit exists

STEP 05

Capture outcomes, objections and changed mandates

Corridor scorecard

  • Mandate-fit opportunities / capabilities
  • Qualified counterparties vs raw names
  • Evidence / references completed
  • Meeting → diligence / pilot / partnership conversion
  • Capital, commercial or strategic outcomes

What VIV deliberately does not do

  • Mass-distribute deals
  • Promise capital or customers
  • Treat the country as one investor segment
  • Use last-round price as current value
  • Bypass regulated specialists where required
LEGAL · RETURN · EXIT · RISK

United States: what can change the investment outcome.

VIV treats corridor access as an investment-and-execution problem, not a list of introductions. The work separates commercial underwriting from regulated legal, tax, valuation and securities work.

01 · LEGAL / STRUCTURE

Know the gates before committing.

Cross-border investments can involve U.S. securities rules, investor-accreditation/private-placement requirements, tax structuring, CFIUS sensitivity in certain sectors and India FEMA/ODI/FDI considerations. VIV scopes the commercial decision and routes regulated legal, tax and securities work to qualified advisers.

VIV control: regulatory-gate checklist, ownership/rights map, specialist hand-off and decision dependencies before capital or counterparties are activated.
02 · ROI DYNAMICS

Underwrite the return, not the story.

Return underwriting should separate operating growth, valuation change, dilution, FX and tax leakage. U.S. growth assets can support large outcomes but entry-price discipline and follow-on reserves materially affect realized returns.

VIV control: base/downside/upside cases, entry-price challenge, dilution and FX sensitivity, milestone-linked follow-on logic and current-value ranges.
03 · EXIT DYNAMICS

Test liquidity before assuming it.

Likely routes include strategic M&A, sponsor/secondary transactions, later financing liquidity and public-market exits where scale permits. Transfer rights, preference stacks and buyer universe are tested before assuming liquidity.

VIV control: rights/transfer review, buyer thesis, strategic/secondary route map, timing assumptions and evidence of real counterparty appetite.
04 · RISK & MITIGATION

Convert risks into monitored decisions.

Key risks include high entry valuations, long private holding periods, litigation/regulatory exposure, customer concentration and USD/INR effects. VIV reduces them through evidence-led valuation, references, downside cases, rights review, milestone monitoring and early buyer mapping.

VIV control: named risk owner, evidence threshold, trigger, mitigation action and escalation decision—hold, follow on, intervene, prepare exit or stop.
VIV RISK-REDUCTION LOOPMANDATE→LEGAL GATES→VERIFY→RETURN CASE→RIGHTS + EXIT→MONITOR→ACT

Country dynamics are a VIV commercial diligence framework, not legal, tax or regulated investment advice. Current transaction-specific requirements must be confirmed by appropriately qualified advisers before execution.

CORRIDOR MOAT

Why the India ↔ US corridor compounds.

US mandate memory

Family, strategic and institutional appetite is retained by stage, sector, ticket, return profile and India relevance, including reasons for passes.

US capability graph

Customers, operators, sector experts, strategic buyers and capital relationships are mapped by concrete capability and permission.

Diligence and exit history

Customer references, valuation objections, governance questions, buyer logic and transaction outcomes improve later US–India decisions.

Discuss your situation